In March 2025, the company announced new strategies for just a immediate-to-shopper supplying of its Wegovy weight loss drug. The company proven a whole new pharmacy, identified as NovoCare, which would charge buyers $499 monthly for usage of the drug, under 50 percent the expense of the drug by means of other pharmaceutical distribution networks.[